Administered as a once-weekly subcutaneous injection, tirzepatide is typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks to a target dose of 5-15 mg as tolerated
Deficiency in the level of activity of glucose-6-phosphate dehydrogenase (G6PD) is the basis of favism, primaquine (an anti-malarial drug) sensitivity and several other drug-sensitive hemolytic anemias, anemia and jaundice in the newborn, and chronic nonspherocytic hemolytic anemia
StatPearls (US source) states, Patients generally receive lifelong intramuscular (IM) injections of vitamin B12 (typically 1000 g per month)
By understanding the nuances of semaglutide treatment, individuals can optimize their health outcomes while minimizing adverse events
The dosage is based on medical condition, response to the treatment, age, and weight